- Home
- TURN vs TELA Comparison
TURN vs TELA Comparison
Compare TURN & TELA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- TURN
- TELA
- Stock Information
- Founded
- TURN 1981
- TELA 2012
- Country
- TURN United States
- TELA United States
- Employees
- TURN N/A
- TELA N/A
- Industry
- TURN Finance/Investors Services
- TELA Medical/Dental Instruments
- Sector
- TURN Finance
- TELA Health Care
- Exchange
- TURN Nasdaq
- TELA Nasdaq
- Market Cap
- TURN 39.9M
- TELA 36.4M
- IPO Year
- TURN N/A
- TELA 2019
- Fundamental
- Price
- TURN $3.93
- TELA $1.89
- Analyst Decision
- TURN
- TELA Strong Buy
- Analyst Count
- TURN 0
- TELA 4
- Target Price
- TURN N/A
- TELA $6.00
- AVG Volume (30 Days)
- TURN 20.3K
- TELA 201.2K
- Earning Date
- TURN 06-17-2025
- TELA 05-08-2025
- Dividend Yield
- TURN N/A
- TELA N/A
- EPS Growth
- TURN N/A
- TELA N/A
- EPS
- TURN N/A
- TELA N/A
- Revenue
- TURN $194,813.00
- TELA $71,217,000.00
- Revenue This Year
- TURN N/A
- TELA $26.67
- Revenue Next Year
- TURN N/A
- TELA $22.63
- P/E Ratio
- TURN N/A
- TELA N/A
- Revenue Growth
- TURN 254.25
- TELA 12.78
- 52 Week Low
- TURN $3.12
- TELA $0.86
- 52 Week High
- TURN $4.25
- TELA $5.86
- Technical
- Relative Strength Index (RSI)
- TURN 45.33
- TELA 75.74
- Support Level
- TURN $3.90
- TELA $1.30
- Resistance Level
- TURN $4.05
- TELA $2.01
- Average True Range (ATR)
- TURN 0.17
- TELA 0.18
- MACD
- TURN -0.02
- TELA 0.07
- Stochastic Oscillator
- TURN 24.42
- TELA 87.50
About TURN 180 Degree Capital Corp.
180 Degree Capital Corp is active in the financial services domain. It is a non-diversified closed-end management investment company whose objective is to achieve long-term capital appreciation by making venture capital investments. It focuses its investments on companies commercializing and integrating products enabled by disruptive technologies mainly in the life sciences, precision medicine, and health industries.
About TELA TELA Bio Inc.
TELA Bio Inc a commercial-stage medical technology company focused on providing innovative soft-tissue reconstruction solutions that optimize clinical outcomes by prioritizing the preservation and restoration of the patient's anatomy. Its growing product portfolio is purposefully designed to leverage the patient's natural healing response while minimizing long-term exposure to permanent synthetic materials. The company's OviTex portfolio consists of multiple product configurations intended to address various surgical procedures within hernia repair and abdominal wall reconstruction, including ventral, inguinal, and hiatal hernia repair.